Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients

INTRODUCTION: Extended-release calcifediol (ERC), active vitamin D hormones and analogs (AVD) and nutritional vitamin D (NVD) are commonly used therapies for treating secondary hyperparathyroidism (SHPT) in adults with stage 3–4 chronic kidney disease (CKD) and vitamin D insufficiency (VDI). Their e...

Descripción completa

Detalles Bibliográficos
Autores principales: Germain, Michael J., Paul, Subir K., Fadda, George, Broumand, Varshasb, Nguyen, Andy, McGarvey, November H., Gitlin, Matthew D., Bishop, Charles W., Csomor, Philipp, Strugnell, Stephen, Ashfaq, Akhtar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650892/
https://www.ncbi.nlm.nih.gov/pubmed/36368937
http://dx.doi.org/10.1186/s12882-022-02993-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650892/
https://www.ncbi.nlm.nih.gov/pubmed/36368937
http://dx.doi.org/10.1186/s12882-022-02993-3

Ejemplares similares